Answers are grounded in this paper and cite their sources.
Cough, fever and tiredness are upper respiratory symptoms of coronavirus disease 2019 (COVID‑19). The emergence of the Delta variant, a significantly mutated and highly transmissible form of the severe acute respiratory syndrome coronavirus 2, initiated a fresh global wave of the COVID-19 pandemic. The timely and accurate clinical outcome prediction is vital for improving the management of patients with COVID‑19 and identifying those who may be severely ill. In this retrospective observational study, a comparison of signs and symptoms and laboratory values was conducted between survivors and non-survivors of the second wave of COVID-19. Severe acute respiratory syndrome coronavirus 2‑positive cases between June, 2021 and January, 2022 were confirmed using reverse transcriptase‑polymerase chain reaction. Medical records were reviewed and collected until patient discharge/mortality. The levels of inflammatory biomarkers, symptoms and comorbidities of the patients were assessed. Analyses were performed using SPSS version 20.0. Of the 200 patients with COVID‑19, 112 were male and 88 were female. Non-survivors outnumbered survivors, with the most common symptoms being sputum production, coughing, and hemoptysis (P≤0.01). Chronic kidney disease and chronic obstructive pulmonary disease were the most common co‑occurring conditions among the non‑survivors. On the day of admission, interleukin (IL)‑6 OR=1.003 (1.000‑1.007), C‑reactive protein OR=1.038 (1.016‑1.059) and lactate dehydrogenase OR=1.004 (1.001‑1.006) levels were measured; however, the most significant predictor of morality were the D‑dimer levels OR=1.016 (1.002‑1.059). Serum ferritin and D‑dimer levels were considerably higher in non‑survivors than in survivors, while IL‑6, C‑reactive protein and lactate dehydrogenase levels were significantly higher in survivors at the time of admission. On day 3 of admission, serum ferritin, D‑dimer, and IL‑6 levels were higher in non‑survivors than in the survivors of COVID‑19. The following factors continued to be significant predictors of mortality among COVID‑19 patients with binary logistic regression: Age, sputum, haemoptysis, cough and chronic obstructive pulmonary disease. Logistic regression analysis revealed that chronic kidney disease was not statistically significant. Understanding the variations in inflammatory profiles is crucial for devising personalized treatment strategies and improving clinical outcomes in the ongoing battle against COVID‑19.
No takes yet. Share an insight, caveat, or question.
Ganai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: